FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

17338311000001107: Larbex XL 4mg tablets (Teva UK Ltd) 28 tablet 2 x 14 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 28-Jul 2010. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
60217001000001110 Larbex XL 4mg tablets (Teva UK Ltd) 28 tablet 2 x 14 tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
60217101000001111 Larbex XL 4mg tablets (Teva UK Ltd) 28 tablet 2 x 14 tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Larbex XL 4mg tablets (Teva UK Ltd) 28 tablet 2 x 14 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Larbex XL 4mg tablets (Teva UK Ltd) 28 tablet 2 x 14 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Larbex XL 4mg tablets (Teva UK Ltd) 28 tablet 2 x 14 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Larbex XL 4mg tablets (Teva UK Ltd) 28 tablet 2 x 14 tablets Is a Doxazosin 4mg modified-release tablets 28 tablet true Inferred relationship Existential restriction modifier
Larbex XL 4mg tablets (Teva UK Ltd) 28 tablet 2 x 14 tablets Has AMP Larbex XL 4mg tablets (Teva UK Ltd) true Inferred relationship Existential restriction modifier
Larbex XL 4mg tablets (Teva UK Ltd) 28 tablet 2 x 14 tablets Has excipient Butylated hydroxytoluene false Inferred relationship Existential restriction modifier
Larbex XL 4mg tablets (Teva UK Ltd) 28 tablet 2 x 14 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Larbex XL 4mg tablets (Teva UK Ltd) 28 tablet 2 x 14 tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Larbex XL 4mg tablets (Teva UK Ltd) 28 tablet 2 x 14 tablets Has specific active ingredient Doxazosin mesilate true Inferred relationship Existential restriction modifier
Larbex XL 4mg tablets (Teva UK Ltd) 28 tablet 2 x 14 tablets Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Larbex XL 4mg tablets (Teva UK Ltd) 28 tablet 2 x 14 tablets Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Doxazosin true Inferred relationship Existential restriction modifier
Larbex XL 4mg tablets (Teva UK Ltd) 28 tablet 2 x 14 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Larbex XL 4mg tablets (Teva UK Ltd) 28 tablet 2 x 14 tablets Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Larbex XL 4mg tablets (Teva UK Ltd) 28 tablet 2 x 14 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Larbex XL 4mg tablets (Teva UK Ltd) 28 tablet 2 x 14 tablets Has basis of strength substance Doxazosin true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start